Switching drugs midstream for patients with chronic myeloid leukemia
DeAngelo, D.J.
Clinical Advances in Hematology and Oncology H&o 12(7): 466-468
2014
ISSN/ISBN: 1543-0790 PMID: 25322328 Document Number: 672752
Document emailed within 1 workday
Related Documents
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Baccarani, M. 1998: SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768 Leukemia 12(7): 1168-1170
Frassoni, F.; Martinelli, G.; Saglio, G.; Sessarego, M.; Podestà, M.; Piaggio, G.; Farabegoli, P.; Zaccaria, A.; Testoni, N.; Remiddi, C. 1995: bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase Bone Marrow Transplantation 16(4): 595-601
Abdulkadyrov, K.M.; Rukavitzyn, O.A.; Bessmel'tsev, S.S.; Lomtev, A.I. 1997: Effect of patients' gender on the course of chronic myeloid leukemia Voprosy Onkologii 43(3): 290-294
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Shen, J.-k.; Zhang, G.-s.; Xiao, L. 2003: Analysis of cytogenetic features in the patients with chronic myeloid leukemia Hunan Yi Ke da Xue Xue Bao 28(4): 431-432
Mendeleev, I.M.; Berliner, G.B.; Miasnikov, A.A.; Polezheav, I.N. 1986: Results of splenectomy with polychemotherapy in the treatment of 15 chronic myeloid leukemia patients Terapevticheskii Arkhiv 58(9): 84-88
Bennour, A.; Ouahchi, I.; Moez, M.; Elloumi, M.; Khelif, A.; Saad, A.; Sennana, H. 2012: Comprehensive Analysis of BCR/ABL Variants in Chronic Myeloid Leukemia Patients Using Multiplex RT-PCR Clinical Laboratory 58(5-6): 433-439
Valent, A.; Zámecníková, A.; Karlic, H.; Nowotny, H.; Krizan, P. 1996: Variant forms of Philadelphia translocation in two patients with chronic myeloid leukemia Neoplasma 43(4): 239-244
Petukhov, V.I.; Bondare, D.K.; Baravika, I.Ia.; Velik, L.V. 1981: Kinetic parameters of proliferating granulocytes in patients with chronic myeloid leukemia Terapevticheskii Arkhiv 53(9): 39-45
Tretiak, N.M.; Bondar, M.V.; Koval', A.I.; Slavchenko, I.I.; Mnyshenko, V.M.; Vakul'chuk, O.M.; Hordiienko, A.I. 1999: The use of Ukrainian laferon in the combined treatment of patients with chronic myeloid leukemia Likars'ka Sprava 5: 131-134
Mahon, F.-X. 2019: When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia? Clinical Advances in Hematology and Oncology: H&o 17(2): 101-103
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Larripa, I.; Ruiz, Mía.Sol.; Gutiérrez, M.; Bianchini, M. 2017: Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR Medicina 77(1): 61-72
Jonte, F.; Fernández-Fuertes, F.; Cecchini, C.; Luño, E.; Ordóñez, A.; Fernández, C.; Suárez, P.; Lausín, A.; Fernández, J. 1992: Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia Sangre 37(5): 351-354
Dou, X.L.; Wang, S.S.; Fang, J.L.; Yu, L.; Ren, X.; Huang, X.J.; Jiang, Q. 2018: Hepatic adverse events associated with tyrosine kinase inhibitors in patients with chronic myeloid leukemia Zhonghua Nei Ke Za Zhi 57(9): 649-655
Sadovnikova, E.I.; Deriugina, E.I.; Drize, N.I.; Udalov, G.A.; Chertkov, I.L. 1989: Long-term culture of bone marrow from patients with PH'-positive chronic myeloid leukemia Gematologiia i Transfuziologiia 34(4): 35-39
Filanovskaia, L.I.; Togo, A.V.; Shcherbakova, E.G.; Blinov, M.N. 1994: Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease Voprosy Meditsinskoi Khimii 40(1): 29-32
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352